Max-Philipp Stenner - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Max-Philipp Stenner

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Archives of Neurology|July 14, 2010

Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathyChristian Wolf, Til Menge, Max-Philipp Stenner, et al.

Journal of Neurophysiology|May 29, 2015

No unified reward prediction error in local field potentials from the human nucleus accumbens: evidence from epilepsy patientsMax-Philipp Stenner, Robb B Rutledge, Tino Zaehle, et al.

Annals of Neurology|June 29, 2010

Upregulation of K2P5.1 potassium channels in multiple sclerosisStefan Bittner, Nicole Bobak, Alexander M Herrmann, et al.

Journal of Neurophysiology|August 4, 2016

Perimovement decrease of alpha/beta oscillations in the human nucleus accumbensMax-Philipp Stenner, Stefan Dürschmid, Robb B Rutledge, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2011

Immunological and clinical consequences of treating a patient with natalizumabNicholas Schwab, Karin G Höhn, Tilman Schneider-Hohendorf, et al.

The American Journal of Pathology|November 2, 2010

Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell deathAlexander M Herrmann, Kerstin Göbel, Ole J Simon, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Archives of Neurology|July 14, 2010

Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathyChristian Wolf, Til Menge, Max-Philipp Stenner, et al.

Journal of Neurophysiology|May 29, 2015

No unified reward prediction error in local field potentials from the human nucleus accumbens: evidence from epilepsy patientsMax-Philipp Stenner, Robb B Rutledge, Tino Zaehle, et al.

Annals of Neurology|June 29, 2010

Upregulation of K2P5.1 potassium channels in multiple sclerosisStefan Bittner, Nicole Bobak, Alexander M Herrmann, et al.

Journal of Neurophysiology|August 4, 2016

Perimovement decrease of alpha/beta oscillations in the human nucleus accumbensMax-Philipp Stenner, Stefan Dürschmid, Robb B Rutledge, et al.

Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2011

Immunological and clinical consequences of treating a patient with natalizumabNicholas Schwab, Karin G Höhn, Tilman Schneider-Hohendorf, et al.

The American Journal of Pathology|November 2, 2010

Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell deathAlexander M Herrmann, Kerstin Göbel, Ole J Simon, et al.

Pageof 4